BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 12515494)

  • 21. Scaffolds for microtubule inhibition through extensive modification of the epothilone template.
    Cachoux F; Isarno T; Wartmann M; Altmann KH
    Angew Chem Int Ed Engl; 2005 Dec; 44(45):7469-73. PubMed ID: 16240301
    [No Abstract]   [Full Text] [Related]  

  • 22. Design, synthesis and biological evaluation of bridged epothilone D analogues.
    Chen QH; Ganesh T; Brodie P; Slebodnick C; Jiang Y; Banerjee A; Bane S; Snyder JP; Kingston DG
    Org Biomol Chem; 2008 Dec; 6(24):4542-52. PubMed ID: 19039362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SAR and pH stability of cyano-substituted epothilones.
    Regueiro-Ren A; Leavitt K; Kim SH; Höfle G; Kiffe M; Gougoutas JZ; DiMarco JD; Lee FY; Fairchild CR; Long BH; Vite GD
    Org Lett; 2002 Oct; 4(22):3815-8. PubMed ID: 12599466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and synthesis of 12-aza-epothilones (azathilones)--"non-natural" natural products with potent anticancer activity.
    Feyen F; Gertsch J; Wartmann M; Altmann KH
    Angew Chem Int Ed Engl; 2006 Sep; 45(35):5880-5. PubMed ID: 16871640
    [No Abstract]   [Full Text] [Related]  

  • 25. Total synthesis of hypermodified epothilone analogs with potent in vitro antitumor activity.
    Kuzniewski CN; Gertsch J; Wartmann M; Altmann KH
    Org Lett; 2008 Mar; 10(6):1183-6. PubMed ID: 18303900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthetic analogues of the microtubule-stabilizing agent (+)-discodermolide: preparation and biological activity.
    Gunasekera SP; Mickel SJ; Daeffler R; Niederer D; Wright AE; Linley P; Pitts T
    J Nat Prod; 2004 May; 67(5):749-56. PubMed ID: 15165132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Total synthesis of epothilone a through stereospecific epoxidation of the p-methoxybenzyl ether of epothilone C.
    Liu ZY; Chen ZC; Yu CZ; Wang RF; Zhang RZ; Huang CS; Yan Z; Cao DR; Sun JB; Li G
    Chemistry; 2002 Aug; 8(16):3747-56. PubMed ID: 12203301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On the remarkable antitumor properties of fludelone: how we got there.
    Rivkin A; Chou TC; Danishefsky SJ
    Angew Chem Int Ed Engl; 2005 May; 44(19):2838-50. PubMed ID: 15880547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of ring-closing metathesis reactions in the synthesis of epothilones.
    Rivkin A; Cho YS; Gabarda AE; Yoshimura F; Danishefsky SJ
    J Nat Prod; 2004 Feb; 67(2):139-43. PubMed ID: 14987048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New analogues of the potent cytotoxic saponin OSW-1.
    Wojtkielewicz A; Długosz M; Maj J; Morzycki JW; Nowakowski M; Renkiewicz J; Strnad M; Swaczynová J; Wilczewska AZ; Wójcik J
    J Med Chem; 2007 Jul; 50(15):3667-73. PubMed ID: 17608396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microbial transformation of epothilone A by Aspergillus niger AS 3.739.
    Wang YL; Wang H; Lu YX; Cheng XC; Han LL; Yuan SJ; Yang DX; Zhang QL; Wu CT
    J Asian Nat Prod Res; 2009; 11(4):357-64. PubMed ID: 19431017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis & antitumor activity of epothilones B and D and their analogs.
    Cheng H; Huang G
    Future Med Chem; 2018 Jun; 10(12):1483-1496. PubMed ID: 29788770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The binding mode of side chain- and C3-modified epothilones to tubulin.
    Erdélyi M; Navarro-Vázquez A; Pfeiffer B; Kuzniewski CN; Felser A; Widmer T; Gertsch J; Pera B; Díaz JF; Altmann KH; Carlomagno T
    ChemMedChem; 2010 Jun; 5(6):911-20. PubMed ID: 20432490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multi-step application of immobilized reagents and scavengers: a total synthesis of epothilone C.
    Storer RI; Takemoto T; Jackson PS; Brown DS; Baxendale IR; Ley SV
    Chemistry; 2004 May; 10(10):2529-47. PubMed ID: 15146525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C6-C8 bridged epothilones: consequences of installing a conformational lock at the edge of the macrocycle.
    Zhan W; Jiang Y; Sharma S; Brodie PJ; Bane S; Kingston DG; Liotta DC; Snyder JP
    Chemistry; 2011 Dec; 17(52):14792-804. PubMed ID: 22127984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Total syntheses of [17]- and [18]dehydrodesoxyepothilones B via a concise ring-closing metathesis-based strategy: correlation of ring size with biological activity in the epothilone series.
    Rivkin A; Njardarson JT; Biswas K; Chou TC; Danishefsky SJ
    J Org Chem; 2002 Nov; 67(22):7737-40. PubMed ID: 12398497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of novel epothilone analogues by means of a common pharmacophore and a QSAR pseudoreceptor model for taxanes and epothilones.
    Forli S; Manetti F; Altmann KH; Botta M
    ChemMedChem; 2010 Jan; 5(1):35-40. PubMed ID: 19904799
    [No Abstract]   [Full Text] [Related]  

  • 38. Synthesis and SAR of C12-C13-oxazoline derivatives of epothilone A.
    Pfeiffer B; Hauenstein K; Merz P; Gertsch J; Altmann KH
    Bioorg Med Chem Lett; 2009 Jul; 19(14):3760-3. PubMed ID: 19433359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New bioactive rosigenin analogues and aromatic polyketide metabolites from the freshwater aquatic fungus Massarina tunicata.
    Oh H; Swenson DC; Gloer JB; Shearer CA
    J Nat Prod; 2003 Jan; 66(1):73-9. PubMed ID: 12542349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extended and clustered conformers of epothilone A.
    Rusinska-Roszak D; Tatka H; Pawlak R; Lozynski M
    J Phys Chem B; 2011 Apr; 115(13):3698-707. PubMed ID: 21405036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.